1.
LDL-cholesterol concentrations: a genome-wide association study
by Sandhu, Manjinder S, Dr
The Lancet (British edition), 2008, Vol.371 (9611), p.483-491
2.
Sudden unexplained death: evaluation of those left behind
by Lee, Adriana
The Lancet (British edition), 2003-11-01, Vol.362 (9394), p.1429-1431
3.
Genotype-specific effects of smoking on risk of CHD
by Li Wang, Xing
The Lancet (British edition), 2001, Vol.358 (9276), p.87-88
4.
Association studies of genetic polymorphisms and complex disease
by Cheung, Bernard MY
The Lancet (British edition), 2000-04-08, Vol.355 (9211), p.1277-1277
5.
Platelet alloantigens: cardiovascular as well as immunological risk factors?
by Newman, Peter J
The Lancet (British edition), 1997, Vol.349 (9049), p.370-371
6.
Understanding cardiovascular development
by Grace, A A
The Lancet (British edition), 1995-04-08, Vol.345 (8954), p.915
7.
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
by Voight, Benjamin F, PhD
The Lancet (British edition), 2012-08-11, Vol.380 (9841), p.572-580
8.
Clinical assessment incorporating a personal genome
by Ashley, Euan A, Dr
The Lancet (British edition), 2010, Vol.375 (9725), p.1525-1535
9.
Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials
by Mega, Jessica L, Dr
The Lancet (British edition), 2015, Vol.385 (9984), p.2264-2271
10.
HDL and cardiovascular disease
by Rader, Daniel J, Prof
The Lancet (British edition), 2014, Vol.384 (9943), p.618-625
11.
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
by Sarwar, Nadeem
The Lancet (British edition), 2012, Vol.379 (9822), p.1205-1213
12.
Triglycerides and cardiovascular disease
by Nordestgaard, Børge G, Prof
The Lancet (British edition), 2014, Vol.384 (9943), p.626-635
13.
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
by Holmes, Michael V
The Lancet (British edition), 2012, Vol.379 (9822), p.1214-1224
14.
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
by Sarwar, Nadeem
The Lancet (British edition), 2010, Vol.375 (9726), p.1634-1639
15.
Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase...
by Greenberg, Barry, Prof
The Lancet (British edition), 2016-03-19, Vol.387 (10024), p.1178-1186
16.
A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses
by Ripatti, Samuli, Dr
The Lancet (British edition), 2010, Vol.376 (9750), p.1393-1400
17.
Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wi...
by Reilly, Muredach P, Dr
The Lancet (British edition), 2011, Vol.377 (9763), p.383-392
18.
Inheritance of coronary artery disease in men: an analysis of the role of the Y chromosome
by Charchar, Fadi J, PhD
The Lancet (British edition), 2012, Vol.379 (9819), p.915-922
19.
Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study
by Talmud, Philippa J, Prof
The Lancet (British edition), 2013, Vol.381 (9874), p.1293-1301
20.
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a...
by Fitzgerald, Kevin, Dr
The Lancet (British edition), 2014, Vol.383 (9911), p.60-68
Filter electronic articles 217 Hits
Remove Filters
- Journal Title
- The Lancet
- Lancet (6)
- Subjects
- Cardiovascular Disease
- Science & Technology (192)
- Medicine, General & Internal (192)
- more ...